Top Markets
#1 Black Phoenix Black Phoenix +743.63%
#2 Islamic Coin Islamic Coin +146.07%
#3 Beam Beam +32.83%
#4 THORChain THORChain +25.51%
#5 TENDIES TENDIES +19.49%
#6 THORChain Yield THORChain Yield +19.43%
#7 SAFEcoin SAFEcoin +18.45%
#8 MiL.k Alliance MiL.k Alliance +16.38%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.02%
#10 Bless Bless +15.60%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Clasificación en acciones #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Precio por acción
$93.80
Última sincronización: 2025-04-28
Capitalización bursátil
$2.68B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Aerovate Therapeutics, Inc. (AVTE)

Categoría

Healthcare
Ganancias de Aerovate Therapeutics, Inc. (AVTE)
Ganancias en Jun 2026 TTM: $-188.80M
Secondo gli ultimi rapporti finanziari di Aerovate Therapeutics, Inc., gli utili attuali della società sono $-188.80M. Nel 2023, la società ha registrato un utile di $-75.47M, una disminución en comparación con agli utili del 2022, che erano di $-51.49M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Aerovate Therapeutics, Inc. desde 2019 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-188.80M 171.37%
2024 $-69.57M -7.81%
2023 $-75.47M 46.57%
2022 $-51.49M 124.24%
2021 $-22.96M 138.89%
2020 $-9.61M 188.62%
2019 $-3.33M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -2,893.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -1,133.17%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 1,535.05%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 2,027.20%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH